Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2017
Prognostic value of dynamic hypoxia PET in head and neck cancer: Results from a planned interim analysis of a randomized phase II hypoxia-image guided dose escalation trialStefan Welz, David Mönnich, Christina Pfannenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 12, 2019
Prospective Evaluation of a Tumor Control Probability Model Based on Dynamic <sup>18</sup>F-FMISO PET for Head and Neck Cancer RadiotherapyDaniela Thorwarth, Stefan Welz, David Mönnich, et al.
Journal for Immunotherapy of Cancer|August 6, 2020
Is there a link between very early changes of primary and secondary lymphoid organs in <sup>18</sup>F-FDG-PET/MRI and treatment response to checkpoint inhibitor therapy?Ferdinand Seith, Andrea Forschner, Benjamin Weide, et al.
Physics and Imaging in Radiation Oncology|October 12, 2020
Comparison of patient stratification by computed tomography radiomics and hypoxia positron emission tomography in head-and-neck cancer radiotherapyJairo A Socarrás Fernández, David Mönnich, Sara Leibfarth, et al.
Annals of Surgical Oncology|March 3, 2009
(18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapyChristina Pfannenberg, Ingmar Königsrainer, Philip Aschoff, et al.
Investigative Radiology|March 31, 2010
Diffusion tensor imaging in a human PET/MR hybrid systemAndreas Boss, Armin Kolb, Matthias Hofmann, et al.
Investigative Radiology|August 19, 2007
Tumor detection by diffusion-weighted MRI and ADC-mapping--initial clinical experiences in comparison to PET-CTMatthias P Lichy, Philip Aschoff, Christian Plathow, et al.
Nuklearmedizin. Nuclear Medicine|June 17, 2020
[Structured reporting in oncologic hybrid imaging: a consensus recommendation]Thorsten Derlin, Sergios Gatidis, Bernd Joachim Krause, et al.
Nature Communications|October 9, 2024
Tumour-informed liquid biopsies to monitor advanced melanoma patients under immune checkpoint inhibitionChristopher Schroeder, Sergios Gatidis, Olga Kelemen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2010
Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center studyGodehard Friedel, Wilfried Budach, Juergen Dippon, et al.
Pageof 11